Baptist Hospital of Miami | PGY-2 Oncology Pharmacy Residency | Baptist Health South Florida http://bapth.lt/1YzSQ0T
Skip Ribbon Commands Skip to main content
Pharmacy Residency Programs

PGY-2 Oncology Pharmacy Residency

Baptist Hospital of Miami

The Specialized Residency in Oncology at Baptist Hospital of Miami is a 12-month training program accredited by the American Society of Health System Pharmacists (ASHP). The purpose of the program is to develop a well-rounded oncology practitioner and effective clinical instructor who can provide high-level clinical care in a variety of oncology settings and effectively share their knowledge and promote learning among students and other residents. The focus of this residency program is adult medical oncology and hematology primarily in an acute care setting with ambulatory care opportunities. The training is coordinated to allow the resident to master each of the disease states established within the ASHP Practice Standards for the PGY2 Residency in Oncology. Residents will develop skills in designing and monitoring evidence-based therapeutic regimens for individuals with cancer to ensure optimal outcomes while minimizing adverse drug events. In addition, the resident will develop skills in leadership, research, and teaching through projects, staff education and co-precepting PGY1 residents and pharmacy students.

After successful completion of this program, the graduating resident will have the necessary skills and preparation to seek board certification in Oncology and demonstrate clinical and leadership abilities as an Oncology Clinical Specialist in an acute care setting.

After successful completion of this program, the graduating resident will have the necessary skills and preparation to seek board certification in Oncology and demonstrate clinical and leadership abilities as an Oncology Clinical Specialist in an acute care setting.

Application requirements

Candidates for this residency must possess a Pharm.D. degree from an ACPE accredited College of Pharmacy and be authorized to work in the United States. The resident must acquire a valid pharmacist license to practice in Florida by August 1st of the residency year.

Applicants must meet the following criteria:

  • Completed a PGY-1 pharmacy residency

Prospective residents are required to submit the following:

  • Curriculum Vitae
  • Official Transcripts from all colleges of pharmacy attended
  • Three (3) letters of recommendation from professional references utilizing standard form required by PhORCAS
  • Personal statement of intent

Acceptance and admission to the program is contingent on submission of all requested materials and meeting all eligibility requirements as determined by the program.

Residency candidates must participate in the Residency Matching Program.

Please submit all materials by the second Friday of January to the Pharmacy Online Residency Centralized Application Service (PhORCAS).

Curriculum summary

Required learning experiences:

  • Medication Utilization I (Chemotherapy preparation and dispensing activities)
  • Medication Utilization II (Oncology Satellite - chemotherapy order processing)
  • Ambulatory Adult Oncology
  • Hematology Inpatient I
  • Hematology Inpatient II
  • Investigational Drug Services
  • Solid Malignancies
  • Pediatric Oncology

Elective learning experiences:

  • Oncology Informatics
  • Pain Management & Palliative Care
  • Pharmacy Administration/Management
  • Oncology Supportive Care and Symptoms Management
  • Teaching Certificate (optional through Nova Southeastern University)

Program Director

Moe Shwin, Pharm.D., BCOP

Moes@baptisthealth.net

Is this program accredited?

Yes, by the American Society of Health-System Pharmacists (ASHP).


How many residents:

One


Preceptor Information